Related Experiment Video

Updated: Jul 16, 2026

Voluntary Breath-hold Technique for Reducing Heart Dose in Left Breast Radiotherapy
11:38

Voluntary Breath-hold Technique for Reducing Heart Dose in Left Breast Radiotherapy

Published on: July 3, 2014

47.3K

Designing and testing a fetal protection system for radiotherapy in pregnant patients

Antonio A Gonçalves1, Tainara G Zandoná2, William S Santos3

  • 1Instituto de Física, Universidade Federal de Uberlândia, Uberlândia, MG, Brazil; Programa de Pós-Graduação em Engenharia Biomédica, FEELT, Universidade Federal de Uberlândia, Uberlândia, MG, Brazil.

Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine
|December 6, 2025
PubMed

Radiotherapy is an effective treatment for cancer, but it should be avoided during pregnancy due to the potential harm to the fetus, which may include malformations, intellectual disability, impaired growth of the head (microcephaly), reduced IQ, and an increased risk of cancer, depending on the gestational age. However, some situations cannot wait until the postpartum period, requiring treatment during pregnancy. The use of mobile shields constructed specially for these specific cases has been reported as a reliable and efficacious way to reduce the fetal doses. In this work, a mobile shield was constructed to be used during the cancer treatment of a pregnant woman's thigh. The shield was built using Monte Carlo simulations and the patient was represented by a voxelized phantom of a 29-year-old pregnant woman. The results show a 26 %-69.5 % reduction on fetal absorbed doses and no extra radiation scattering to the patient, meaning that the mobile shield is safe and efficient.

Keywords:
Fetal doseMobile shieldsMonte Carlo simulationPregnancyRadiation therapy

More Related Videos

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

20.9K
Author Spotlight: Improving Radiation Therapy Access with Radiation Planning Assistant05:18

Author Spotlight: Improving Radiation Therapy Access with Radiation Planning Assistant

Published on: October 6, 2023

1.8K

Related Concept Videos

Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Radiological Investigation III: Pulmonary Angiogram and PET Scan01:13

Radiological Investigation III: Pulmonary Angiogram and PET Scan

Radiological investigations are paramount in the diagnosis and management of various pulmonary diseases. Two essential investigations are the Pulmonary Angiogram and the Positron Emission Tomography (PET) Scan.
Pulmonary Angiogram
A Pulmonary Angiogram is an invasive procedure involving injecting a contrast medium through a catheter threaded into the pulmonary artery or the right side of the heart to visualize the pulmonary vasculature. Computed Tomography (CT) scans have mainly replaced this...
Imaging Studies II: Positron Emission Tomography and Scintigraphy01:25

Imaging Studies II: Positron Emission Tomography and Scintigraphy

Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET
Intrauterine Drug Delivery Systems01:21

Intrauterine Drug Delivery Systems

Controlled-release systems for intravaginal and intrauterine drug delivery have been developed primarily for the administration of contraceptive steroid hormones. These delivery routes circumvent first-pass hepatic metabolism, thereby enhancing bioavailability and allowing for reduced systemic dosages compared to oral administration. Such approaches contribute to improved therapeutic efficacy and patient compliance, particularly in long-term contraceptive regimens.Intravaginal Drug Delivery...